BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7912567)

  • 1. Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study.
    Toi M; Tominaga T; Osaki A; Toge T
    Breast Cancer Res Treat; 1994 Jan; 29(1):51-8. PubMed ID: 7912567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma.
    Gasparini G; Boracchi P; Bevilacqua P; Mezzetti M; Pozza F; Weidner N
    Breast Cancer Res Treat; 1994 Jan; 29(1):59-71. PubMed ID: 7912568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
    Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
    J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
    Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
    Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
    Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
    Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu.
    Harris AL; Nicholson S; Sainsbury JR; Farndon J; Wright C
    J Steroid Biochem; 1989; 34(1-6):123-31. PubMed ID: 2576295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
    Gasparini G; Weidner N; Bevilacqua P; Maluta S; Dalla Palma P; Caffo O; Barbareschi M; Boracchi P; Marubini E; Pozza F
    J Clin Oncol; 1994 Mar; 12(3):454-66. PubMed ID: 7509851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.
    Fox SB; Smith K; Hollyer J; Greenall M; Hastrich D; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):41-9. PubMed ID: 8018963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
    Lipponen P; Eskelinen M
    Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    Breast Cancer Res Treat; 2002 Jan; 71(1):67-75. PubMed ID: 11859875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
    Wright C; Nicholson S; Angus B; Sainsbury JR; Farndon J; Cairns J; Harris AL; Horne CH
    Br J Cancer; 1992 Jan; 65(1):118-21. PubMed ID: 1346366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.
    Fox SB; Leek RD; Smith K; Hollyer J; Greenall M; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):109-16. PubMed ID: 7517221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma.
    Tauchi K; Hori S; Itoh H; Osamura RY; Tokuda Y; Tajima T
    Virchows Arch A Pathol Anat Histopathol; 1989; 416(1):65-73. PubMed ID: 2573192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion.
    Toi M; Hamada Y; Nakamura T; Mukaida H; Suehiro S; Wada T; Toge T; Niimoto M; Hattori T
    Int J Cancer; 1989 Feb; 43(2):220-5. PubMed ID: 2645219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study.
    Gasparini G; Gullick WJ; Maluta S; Dalla Palma P; Caffo O; Leonardi E; Boracchi P; Pozza F; Lemoine NR; Bevilacqua P
    Eur J Cancer; 1994; 30A(1):16-22. PubMed ID: 7908213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.
    Toi M; Nakamura T; Mukaida H; Wada T; Osaki A; Yamada H; Toge T; Niimoto M; Hattori T
    Cancer; 1990 May; 65(9):1980-4. PubMed ID: 2372767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
    Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
    Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer.
    Gasparini G; Bevilacqua P; Pozza F; Meli S; Boracchi P; Marubini E; Sainsbury JR
    Br J Cancer; 1992 Nov; 66(5):970-6. PubMed ID: 1419645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up.
    Ferrero JM; Ramaioli A; Largillier R; Formento JL; Francoual M; Ettore F; Namer M; Milano G
    Ann Oncol; 2001 Jun; 12(6):841-6. PubMed ID: 11484962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.